
AI Drug Discovery Pioneer InSilico Medicine Launches Hong Kong IPO, With Backing From Lilly, Tencent
AI biotech firm InSilico Medicine is launching a major Hong Kong IPO, backed by cornerstone investments from Eli Lilly and Tencent, among others.
Showing 3 of 3 posts with this tag

AI biotech firm InSilico Medicine is launching a major Hong Kong IPO, backed by cornerstone investments from Eli Lilly and Tencent, among others.

Starna Therapeutics, a Chinese firm focusing on the research and development of new mRNA drugs, recently announced the completion of round-A financing totaling 150 million yuan ($22.1 million).

Yaoshibang, a Chinese pharmaceutical distribution platform, submitted an application on Tuesday for a public listing to the Hong Kong Stock Exchange (HKEx), with Goldman Sachs and CICC named as co-sponsors.